107 related articles for article (PubMed ID: 17387689)
1. Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
Ono K; Hirohata M; Yamada M
J Neurosci Res; 2007 May; 85(7):1547-57. PubMed ID: 17387689
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Ono K; Yamada M
J Neurochem; 2006 Apr; 97(1):105-15. PubMed ID: 16524383
[TBL] [Abstract][Full Text] [Related]
3. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Neurochem Int; 2006 Mar; 48(4):275-85. PubMed ID: 16343694
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Hirohata M; Ono K; Morinaga A; Yamada M
Neuropharmacology; 2008 Mar; 54(3):620-7. PubMed ID: 18164319
[TBL] [Abstract][Full Text] [Related]
5. Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases.
Ono K; Yamada M
Neurobiol Dis; 2007 Feb; 25(2):446-54. PubMed ID: 17169566
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases.
Ono K; Hirohata M; Yamada M
Exp Neurol; 2007 Jun; 205(2):414-24. PubMed ID: 17425956
[TBL] [Abstract][Full Text] [Related]
7. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
[TBL] [Abstract][Full Text] [Related]
8. Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.
Ono K; Takasaki J; Takahashi R; Ikeda T; Yamada M
J Neurosci Res; 2013 Oct; 91(10):1371-81. PubMed ID: 23913715
[TBL] [Abstract][Full Text] [Related]
9. Effect of melatonin on α-synuclein self-assembly and cytotoxicity.
Ono K; Mochizuki H; Ikeda T; Nihira T; Takasaki J; Teplow DB; Yamada M
Neurobiol Aging; 2012 Sep; 33(9):2172-85. PubMed ID: 22118903
[TBL] [Abstract][Full Text] [Related]
10. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2005 Oct; 336(2):444-9. PubMed ID: 16153607
[TBL] [Abstract][Full Text] [Related]
11. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochem Biophys Res Commun; 2005 Apr; 330(1):111-6. PubMed ID: 15781239
[TBL] [Abstract][Full Text] [Related]
12. Anti-aggregation and fibril-destabilizing effects of sex hormones on alpha-synuclein fibrils in vitro.
Hirohata M; Ono K; Morinaga A; Ikeda T; Yamada M
Exp Neurol; 2009 Jun; 217(2):434-9. PubMed ID: 19289119
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders.
Ono K; Hirohata M; Yamada M
Curr Pharm Des; 2008; 14(30):3247-66. PubMed ID: 19075704
[TBL] [Abstract][Full Text] [Related]
14. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2006 Mar; 341(4):1046-52. PubMed ID: 16460684
[TBL] [Abstract][Full Text] [Related]
15. The anti-Parkinsonian drug selegiline delays the nucleation phase of α-synuclein aggregation leading to the formation of nontoxic species.
Braga CA; Follmer C; Palhano FL; Khattar E; Freitas MS; Romão L; Di Giovanni S; Lashuel HA; Silva JL; Foguel D
J Mol Biol; 2011 Jan; 405(1):254-73. PubMed ID: 21050861
[TBL] [Abstract][Full Text] [Related]
16. Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
Exp Neurol; 2004 Oct; 189(2):380-92. PubMed ID: 15380488
[TBL] [Abstract][Full Text] [Related]
17. beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
Kim YS; Lim D; Kim JY; Kang SJ; Kim YH; Im H
Biochem Biophys Res Commun; 2009 Oct; 387(4):682-7. PubMed ID: 19622344
[TBL] [Abstract][Full Text] [Related]
18. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
Luk KC; Hyde EG; Trojanowski JQ; Lee VM
Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation.
Hirohata M; Ono K; Morinaga A; Ikeda T; Yamada M
Neurosci Lett; 2011 Mar; 491(1):48-52. PubMed ID: 21215793
[TBL] [Abstract][Full Text] [Related]
20. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.
Morinaga A; Hirohata M; Ono K; Yamada M
Biochem Biophys Res Commun; 2007 Aug; 359(3):697-702. PubMed ID: 17559807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]